These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34370066)

  • 1. Association between topical β-blocker use and asthma attacks in glaucoma patients with asthma: a cohort study using a claims database.
    Kido A; Miyake M; Akagi T; Ikeda HO; Kameda T; Suda K; Hasegawa T; Hiragi S; Yoshida S; Tsujikawa A; Tamura H; Kawakami K
    Graefes Arch Clin Exp Ophthalmol; 2022 Jan; 260(1):271-280. PubMed ID: 34370066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resource Utilization Among Glaucoma Patients in the UK Treated with Beta-Blocker and Non-Beta-Blocker Adjunctive Therapy: A Retrospective Cohort Analysis.
    Viswanathan A; Spera C; Mullins A; Covert D; Banhazi J; McDwyer P; Hudson E; Ferreira A
    Adv Ther; 2017 Jul; 34(7):1695-1706. PubMed ID: 28608143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of risk of falls and orthostatic hypotension in older, long-term topical beta-blocker users.
    Ramdas WD; van der Velde N; van der Cammen TJ; Wolfs RC
    Graefes Arch Clin Exp Ophthalmol; 2009 Sep; 247(9):1235-41. PubMed ID: 19452162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription of topical antiglaucoma agents for patients with contraindications to beta-blockers.
    Houde M; Castilloux AM; Tingey D; Assalian A; LeLorier J
    Can J Ophthalmol; 2003 Oct; 38(6):469-75. PubMed ID: 14620034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical beta-blockers and mortality.
    Müskens RP; Wolfs RC; Witteman JC; Hofman A; de Jong PT; Stricker BH; Jansonius NM
    Ophthalmology; 2008 Nov; 115(11):2037-43. PubMed ID: 18801580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resting pulse rates in a glaucoma clinic: the effect of topical and systemic beta-blocker usage.
    Tattersall C; Vernon S; Singh R
    Eye (Lond); 2006 Feb; 20(2):221-5. PubMed ID: 15803169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs and persistence of carbonic anhydrase inhibitor versus alpha-2 agonists, associated with beta-blockers, in glaucoma and ocular hypertension: an analysis of the UK-GPRD database.
    Lafuma A; Berdeaux G
    Curr Med Res Opin; 2008 May; 24(5):1519-27. PubMed ID: 18413015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical beta blockers in asthmatic patients-is it safe?
    Kaiserman I; Fendyur A; Vinker S
    Curr Eye Res; 2009 Jul; 34(7):517-22. PubMed ID: 19899964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the Association between Topical Prostaglandin F2α Analogs and Asthma Using the JADER Database: Comparison with β-Blockers].
    Ohyama K; Sugiura M
    Yakugaku Zasshi; 2018; 138(4):559-564. PubMed ID: 29608006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence and adherence with topical glaucoma therapy.
    Nordstrom BL; Friedman DS; Mozaffari E; Quigley HA; Walker AM
    Am J Ophthalmol; 2005 Oct; 140(4):598-606. PubMed ID: 16226511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical Beta-Blockers and Cardiovascular Mortality: Systematic Review and Meta-Analysis with Data from the EPIC-Norfolk Cohort Study.
    Pinnock C; Yip JL; Khawaja AP; Luben R; Hayat S; Broadway DC; Foster PJ; Khaw KT; Wareham N
    Ophthalmic Epidemiol; 2016 Oct; 23(5):277-84. PubMed ID: 27551956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spirometry for patients prescribed topical beta-blockers.
    Snape JP; Waldock A
    Nurs Stand; 2000 Oct 11-17; 15(4):35-8. PubMed ID: 11971492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of obstructive airways disease in a glaucoma population.
    Huerta C; García Rodríguez LA; Möller CS; Arellano FM
    Pharmacoepidemiol Drug Saf; 2001; 10(2):157-63. PubMed ID: 11499855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing Initial Glaucoma Medical Therapy Increases Healthcare Resource Utilization.
    Trese MGJ; Lewis AW; Blachley TS; Stein JD; Moroi SE
    J Ocul Pharmacol Ther; 2017 Oct; 33(8):591-597. PubMed ID: 28854348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical service encounters and payments associated with topical adjunctive therapy use of timolol for glaucoma.
    Schmier JK; Covert DW; Lau EC
    Clin Drug Investig; 2012 Dec; 32(12):835-42. PubMed ID: 23138648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenergic glaucoma drugs reduce lymphatic clearance from the eye: A sequential photoacoustic imaging study.
    Hanna J; Yücel YH; Zhou X; Kim N; Irving H; Gupta N
    Exp Eye Res; 2021 Nov; 212():108775. PubMed ID: 34599970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
    Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
    Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of beta-blocker use in people with asthma.
    Graft DF; Fowles J; McCoy CE; Lager RA
    Ann Allergy; 1992 Nov; 69(5):449-53. PubMed ID: 1360775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory effect of beta-blocker eye drops in asthma: population-based study and meta-analysis of clinical trials.
    Morales DR; Dreischulte T; Lipworth BJ; Donnan PT; Jackson C; Guthrie B
    Br J Clin Pharmacol; 2016 Sep; 82(3):814-22. PubMed ID: 27161880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uveitis associated with topical beta-blockers.
    Beck RW; Moke P; Blair RC; Nissenbaum R
    Arch Ophthalmol; 1996 Oct; 114(10):1181-2. PubMed ID: 8859074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.